Phân loại và phân loại viêm khớp psoriatic

Helliwell PS, Porter G, Taylor WJ (2007) Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 66(1):113–117 McGonagle D, Conaghan PG, Emery P (1999) Psoriatic arthritis: a unified concept twenty years on [see comment][erratum appears in Arthritis Rheum 1999 Sep;42(9):1997]. Arthritis Rheum 42(6):1080–1086 Kruithof E, Baeten D, De Rycke L, Vandooren B, Foell D, Roth J et al (2005) Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 7(3):R569–R580 Veale DJ, Ritchlin C, FitzGerald O (2005) Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis 64(Suppl 2):ii26–ii29 Gladman DD, Farewell VT, Wong K, Husted J (1998) Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41(6):1103–1110 Sihvonen S, Korpela M, Laippala P, Mustonen J, Pasternack A (2004) Death rates and causes of death in patients with rheumatoid arthritis: a population-based study. Scand J Rheumatol 33(4):221–227 Gorter S, van der Heijde DM, van der Linden S, Houben H, Rethans JJ, Scherpbier AJ et al (2002) Psoriatic arthritis: performance of rheumatologists in daily practice. Ann Rheum Dis 61(3):219–224 Symmons DP, Lunt M, Watkins G, Helliwell P, Jones S, McHugh N et al (2006) Developing classification criteria for peripheral joint psoriatic arthritis Step. I. Establishing whether the rheumatologist’s opinion on the diagnosis can be used as the “gold standard”. J Rheumatol 33(3):552–557 Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3(1):55–78 Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK (1987) Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med 62(238):127–141 Bennett RM (1979) Psoriatic arthritis, 9th edn. Lea & Febiger, Philadelphia Vasey F, Espinoza LR (1987) Psoriatic arthropathy. Grune & Stratton, Orlando Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy [see comment]. Arthritis Rheum 34(10):1218–1227 Fournie B, Crognier L, Arnaud C, Zabraniecki L, Lascaux-Lefebvre V, Marc V et al (1999) Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients. Rev Rhum (Engl Ed) 66(10):446–456 Biondi Oriente C, Scarpa R, Pucino A, Oriente P (1989) Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report. Acta Derm Venereol Suppl (Stockh) 146:69–71 Helliwell P, Marchesoni A, Peters M, Barker M, Wright V (1991) A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 30(5):339–345 Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33(9):834–839 Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C (1991) Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 30(4):245–250 Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673 Taylor WJ, Marchesoni A, Arreghini M, Sokoll K, Helliwell PS (2004) A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis. Semin Arthritis Rheum 34(3):575–584 Chandran V, Schentag CT, Gladman DD (2007) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 57(8):1560–1563 Wright V (1959) Rheumatism and psoriasis: a re-evaluation. Am J Med 27:454–462 Veale D, FitzGerald O (1992) Psoriatic arthritis—“DIP or not DIP? That is the question”. Br J Rheumatol 31(6):430–431 Khan M, Schentag C, Gladman DD (2003) Clinical and radiological changes during psoriatic arthritis disease progression. J Rheumatol 30(5):1022–1026 Bennett AN, McGonagle D, O, Connor P, Hensor E, Coates LC, Emery P et al (2008) Early inflammatory back pain and MRI sacroiliitis: severity of osteitis at baseline and HLA B27 predict ankylosing spondylitis at 8 years. Rheumatology 47(S2):ii5 (abstract) Williamson L, Dockerty JL, Dalbeth N, McNally E, Ostlere S, Wordsworth BP (2004) Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis. Rheumatology (Oxford) 43(1):85–88 Gladman DD, Anhorn KA, Schachter RK, Mervart H (1986) HLA antigens in psoriatic arthritis. J Rheumatol 13(3):586–592 McHugh NJ, Laurent MR, Treadwell BL, Tweed JM, Dagger J (1987) Psoriatic arthritis: clinical subgroups and histocompatibility antigens. Ann Rheum Dis 46(3):184–188 Marsal S, Armadans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E (1999) Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford) 38(4):332–337 Kane D, Stafford L, Bresnihan B, FitzGerald O (2003) A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis—‘DIP or not DIP revisited’. Rheumatology (Oxford) 42(12):1469–1476 Backhaus M, Burmester GR, Sandrock D, Loreck D, Hess D, Scholz A et al (2002) Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints. Ann Rheum Dis 61(10):895–904 Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW, McGonagle D et al (2004) Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis 63(4):382–385 Gladman DD, Farewell VT, Nadeau C (1995) Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol 22(4):675–679 Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T et al (1996) Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39(12):2013–2020 Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C et al (2005) Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 64(8):1150–1157 Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial [see comment]. Lancet 356(9227):385–390 Korendowych E, Dixey J, Cox B, Jones S, McHugh N (2003) The influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. J Rheumatol 30(1):96–101 Ho PY, Barton A, Worthington J, Plant D, Griffiths CE, Young HS et al (2007) Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis 67:677–682 Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N (2005) The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology (Oxford) 44(8):1056–1060 Taylor WJ, Zmierczak HG, Helliwell PS (2005) Problems with the definition of axial and peripheral disease patterns in psoriatic arthritis. J Rheumatol 32(6):974–977